Recorded Webinar: Bringing a Strategic Integrated Evidence Approach to Life

We agree on why an integrated approach to evidence is essential. Here, we delve deeper into how to bring it to life, and what a great integrated approach looks like.

Life science innovators (pharmaceuticals, medtech, devices) aim to get safe, effective, valuable innovations to patients as soon as possible. Regulators, health technology assessors (HTAs) and payers also exist to serve patients via their rigorous evaluation of safety, efficacy, cost-effectiveness, and affordability. Each of these stakeholders rely on access to timely, robust, and joined-up evidence to make decisions.

To meet these evidence requirements, product developers agree on the need to have a cross-functional, integrated approach to evidence generation outlined by phase II or even earlier – bringing consensus on why an integrated approach to evidence is essential.  

We flagged the various environmental factors making this essential and urgent in our recent article Integrated Evidence Generation is No Longer a Nice-to-Have: 3 Reasons Why. 

View this recording of our recent webinar where we chat with seasoned industry leaders to explore:

• WHY strategic integrated evidence generation unlocks compounded benefits including accelerated patient access, enhanced efficiency, reduced overall costs, and better ways of working (for example, earlier cross-functional alignment and cohesion around a launch asset)
• HOW a strategic integrated approach can be adopted in your unique team structure utilizing a core iterative learning approach – assessment, prioritization, execution.
• WHAT helps unlock this combination of strategic mindset and operational excellence. And – just as important – knowing what is not meant when industry partners and we at RTI-HS refer to a ‘strategic integrated approach.’